Published in Pharma Law Weekly, March 27th, 2007
This trend article about Sidney Kimmel Cancer Center, San Diego, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer," is the subject of a report. "S.c. injection of the Ad-sig-tumor-associated antigen (TAA)/ecdCD40L vector vaccine has been shown to induce a CD8 immune response against TAA for up to 1 year. The first goal of this article is to test if the injection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly